Back to Journals » Adolescent Health, Medicine and Therapeutics » Volume 1

Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies

Authors Yeh EA

Published 30 July 2010 Volume 2010:1 Pages 61—71


Review by Single-blind

Peer reviewer comments 4

E Ann Yeh

Department of Neurology, Pediatric MS Center of the JNI, SUNY Buffalo, Buffalo, NY, USA

Abstract: Pediatric-onset multiple sclerosis (MS) comprises approximately 3%–5% of cases of MS in North America. Recent years have seen significant advances in the diagnosis and treatment of this condition, including the introduction of proposed diagnostic criteria for pediatric demyelinating disorders, and a growing body of knowledge regarding treatment options. This article reviews current approaches to the diagnosis and management of pediatric MS.

Keywords: pediatric, therapy, interferon, glatiramer acetate, chemotherapy, breakthrough disease, definitions, MRI

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]